Guidance on the use of long-acting insulin analogues for the treatment of diabetes – insulin glargine

NICE technology appraisals [TA53] Published date:

NICE has recommended insulin glargine as an option for people with type 1 diabetes. For people with type 2 diabetes who need to take insulin, NICE has recommended that insulin glargine should be an option only if the person:

  • needs help with his or her insulin injections from a carer or healthcare professional, or 
  • has repeated and unpleasant hypoglycaemic episodes that significantly affect his or her way of life, or 
  • would otherwise need to have two insulin injections to maintain background levels every day as well as having to take other diabetes medicines orally.

  • The recommendations in this technology appraisal relating to type 2 diabetes have been replaced by recommendations in the Diabetes - type 2 (update) clinical guideline published in May 2008. Please note that the recommendations in this technology appraisal relating to type 1 diabetes have not changed.

  • Get involved